Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Catherine Arendt
Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes From Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2)
SKIN The Journal of Cutaneous Medicine
Related publications
The Course of Chronic Plaque-Type Psoriasis in Placebo Groups of Randomized Controlled Studies
Archives of Dermatology
Patient-Reported Outcomes From Two Randomized, Double-Blind, Vehicle Controlled Phase 3 Trials in Axillary Hyperhidrosis (ATMOS-1 & ATMOS-2)
SKIN The Journal of Cutaneous Medicine
Serlopitant for the Treatment of Chronic Pruritus: Results of a Randomized, Multicenter, Placebo-Controlled Phase 2 Clinical Trial
Journal of the American Academy of Dermatology
Dermatology
The Efficacy of Certolizumab Pegol Re-Treatment on Plaque Psoriasis Following a Blinded Treatment Break: Results From the CIMPACT Trial
SKIN The Journal of Cutaneous Medicine
Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study
SKIN The Journal of Cutaneous Medicine
Adalimumab for Nail Psoriasis: Efficacy and Safety Over 52 Weeks From a Phase‐3, Randomized, Placebo‐Controlled Trial
Journal of the European Academy of Dermatology and Venereology
Dermatology
Infectious Diseases
Patient-Reported Outcomes of Multiple Myeloma Patients Treated With Panobinostat After ≥2 Lines of Therapy Based on the International Phase 3, Randomized, Double-Blind, Placebo-Controlled PANORAMA-1 Trial
British Journal of Haematology
Hematology
Adalimumab for Nail Psoriasis: Efficacy and Safety From the First 26 weeks of a Phase 3, Randomized, Placebo-Controlled Trial
Journal of the American Academy of Dermatology
Dermatology
Adalimumab for Nail Psoriasis: Efficacy and Safety From the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial
SKIN The Journal of Cutaneous Medicine
